respiratory syncytial virus

News

GSK claims first EU approval for an RSV vaccine

GSK’s Arexvy has become the first vaccine for respiratory syncytial virus (RSV) to be approved in the EU, getting the nod from the European Commission for use in older adu

News

After FDA nod, Pfizer joins GSK in RSV vaccine market

The FDA has approved Pfizer’s respiratory syncytial virus (RSV) vaccine for older adults, just a few weeks after a rival shot from GSK became the first to be cleared in th

News

FDA advisors back Pfizer’s RSV shot for maternal use

An FDA advisory committee has endorsed Pfizer’s respiratory syncytial virus (RSV) vaccine for use in expectant mothers, potentially opening up a niche for the shot, where

News

Caution urged as Pfizer’s maternal RSV shot adcomm nears

There have been calls for caution when it comes to the use of Pfizer’s respiratory syncytial virus (RSV) vaccine in pregnant women, ahead of an FDA advisory committee meet

News

GSK claims first global approval for an RSV vaccine

GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting up what looks set to be a highly lucrat

News

GSK’s RSV vaccine in EU pole position after CHMP backing

GSK looks set to bring the first vaccine for respiratory syncytial virus (RSV) to market in the EU, after its Arexvy shot was recommended for approval by the EMA’s human m

GSK claims first EU approval for an RSV vaccine

After FDA nod, Pfizer joins GSK in RSV vaccine market

FDA advisors back Pfizer’s RSV shot for maternal use

Caution urged as Pfizer’s maternal RSV shot adcomm nears

GSK claims first global approval for an RSV vaccine

GSK’s RSV vaccine in EU pole position after CHMP backing

NHS use of digital cardiac rehab tools endorsed

How to meet your physicians where they are online

respiratory syncytial virus

Editor's Picks